Stay updated with breaking news from Robert Andrade. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DG Capital Management LLC cut its holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) by 5.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,075,634 shares of the company’s stock after selling 67,465 shares during the period. Fennec Pharmaceuticals accounts […]
~ Fourth Quarter 2023 Net Revenues of Approximately $9.2 to $9.7 Million ~ ~ Company Expects to Report 2023 Fourth Quarter and Audited Full-Year Results on or about March 26, 2024 ~ RESEARCH...
RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2024 -- Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration has...
“More attempts to chill free speech in the ‘free’ State of Florida,” said one Democratic lawmaker.
~ Supports Strategic Discussions and Global Launch Activities ~ ~ Extends Access to Additional Undrawn Capital As Needed During Global PEDMARK® Rollout ~ ~ Facilitates Market Expansion...